Depression Treatment among Adults with Multiple Sclerosis and Depression in Ambulatory Care Settings in the United States

Table 3

Predictors of depression treatment among adults with MS and depression (NAMCS-NHAMCS 2005–2011).

Characteristics	AOR	95% CI	Sig
Predisposing factors
Age
18–39	Ref
≥40	0.189	[0.036, 0.997]	0.0496
Gender
Female	Ref
Male	0.970	[0.303, 3.104]	0.9591
Race/ethnicity
White Only, NH	0.848	[0.214, 3.360]	0.8144
Other	Ref
Georegion
South	1.187	[0.475, 2.962]	0.7138
Other	Ref
Metro
Metro	Ref
Nonmetro	0.929	[0.172, 5.034]	0.9321
Enabling Factors
Physpec/clinical specialty
Gen & fam prac	Ref
Others	0.884	[0.216, 3.617]	0.8639
Insurance
Govt. insurance	Ref
Others	3.379	[0.924, 12.354]	0.0656
Need Factors
Reason visit
Chronic prob, rout	Ref
Others	0.734	[0.256, 2.107]	0.5658
New prescription
No new meds	Ref
≥1 new med	0.356	[0.118, 1.070]	0.0659
Disease modifying drugs
Yes	1.115	[0.314, 3.955]	0.8662
No
NUMMED	1.352	[0.987, 1.852]	0.0604
TOTCHRON	0.554	[0.335, 0.917]	0.0216

Note. Based on 220 (nationally representative weighted million) ambulatory visits of adults (age ≥ 18 years) with Multiple Sclerosis and depression using NAMCS and NHAMCS 2005–2011 data.
MS: Multiple Sclerosis; NAMCS: National Ambulatory Medical Care Survey; NHAMCS: National Hospital Ambulatory Medical Care Survey; Ref: reference group; AOR: Adjusted Odds Ratio; CI: confidence interval; Sig: significance; NH: Non-Hispanic; Physpec: Physician Specialty; Gen & fam prac: general and family practice; Chron prob: chronic problem; NUMMED: total number of medications; TOTCHRON: total number of chronic conditions.
Statistically significant at 5.